openPR Logo
Press release

ER+ Breast Cancer Pipeline Analysis - Clinical Trials, Patent, Designation and Collaboration

ER+ Breast Cancer Pipeline Analysis - Clinical Trials, Patent,

The study analyzed that the estrogen receptor positive breast cancer pipeline comprises approximately 74 drug candidates in different stages of development.

Explore report sample at: https://www.psmarketresearch.com/market-analysis/estrogen-receptor-positive-breast-cancer-pipeline-analysis/report-sample

Chipscreen Biosciences, Ltd. is using chemo genomics approach for the development of their drug candidates in ER+ breast cancer. The approach connects small molecule structures to disease targets and therapeutic functions to accelerate the discovery process by effectively comparing the molecular profiles of successful drugs, failed drugs, and classical toxins.

The research finds that different companies have collaborated for the development of ER+ breast cancer. In January 2016, Radius Health, Inc. entered in a worldwide clinical collaboration with Novartis Pharmaceuticals to evaluate the safety and efficacy of combining investigational agent RAD1901 with LEE011 for advanced breast cancer.

Browse Report at: https://www.psmarketresearch.com/market-analysis/estrogen-receptor-positive-breast-cancer-pipeline-analysis

Some of the key players developing drugs for Estrogen Receptor-Positive (ER+) breast cancer are Chipscreen Biosciences, Ltd., Eli Lilly & Company, Genentech, Inc., and others.

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release ER+ Breast Cancer Pipeline Analysis - Clinical Trials, Patent, Designation and Collaboration here

News-ID: 1209114 • Views:

More Releases from P&S Intelligence - Pharmaceuticals

Cyclin-Dependent Kinase Inhibitors Therapeutics Key Players Analysis - Merck, Eli Lilly and Company, AstraZeneca, Boehringer Ingelheim
Cyclin-Dependent Kinase Inhibitors Therapeutics Key Players Analysis - Merck, El …
The study analyzed that the CDK inhibitors therapeutics pipeline comprises approximately 24 drug candidates in different stages of development. CDKs are the catalytic subunits of serine or threonine protein kinases that regulate the checkpoints in the cell cycle to control the proliferative capacity of cancerous cells. These proteins form cyclin-CDK complex which gets activated after phosphorylation, leading to cell proliferation. Download report sample at: http://bit.ly/2eqiPu5 **Various collaborations for CDK inhibitors drug development Eli Lilly
Systemic Lupus Erythematosus Pipeline Analysis - Anthera Pharmaceuticals, Inc., Genentech, Inc., Merck KGaA
Systemic Lupus Erythematosus Pipeline Analysis - Anthera Pharmaceuticals, Inc., …
The study analyzed that the systemic lupus erythematosus pipeline comprises of 57 drug candidates in different stages of development. Explore report sample at: https://www.psmarketresearch.com/market-analysis/systemic-lupus-erythematosus-pipeline-analysis/report-sample Systemic lupus erythematosus is a type of lupus in which the immune system damages its own tissues. The disease affects many parts of the body including skin, joints, lungs, brain, blood vessels and kidneys. The systemic lupus erythematosus is caused by impaired immune system due to which the
Herpes Simplex Virus Infections Therapeutic - Pipeline Analysis, Clinical Trials and Developments
Herpes Simplex Virus Infections Therapeutic - Pipeline Analysis, Clinical Trials …
The study analysed that the Herpes simplex virus infections pipeline comprises of 20 drug candidates in different stages of development. As per the findings of the research, most of the drug candidates are being developed to be administered by oral route. Explore report sample at: https://www.psmarketresearch.com/market-analysis/hsv-infections-therapeutics-pipeline-analysis/report-sample Many technologies are being developed that offer promising innovative treatments which can control the progression of Herpes simplex virus infections. The technologies include, but not limited to,
Japanese Encephalitis Therapeutics - Pipeline Analysis, Clinical Trials, Patent and Collaborations
Japanese Encephalitis Therapeutics - Pipeline Analysis, Clinical Trials, Patent …
Japanese encephalitis is a viral infection that spreads by mosquito bites. The study analyzed that the Japanese encephalitis therapeutics pipeline comprises approximately 12 drug candidates in different stages of development. Explore report sample at: https://www.psmarketresearch.com/market-analysis/japanese-encephalitis-therapeutics-pipeline/report-sample The companies developing drugs for the treatment of Japanese encephalitis are laying more emphasis on the drug candidates to be developed as vaccines, due to the promising results shown by these candidates the in the clinical development.

All 5 Releases


More Releases for ER+

Perle releases eR-S1110 Ethernet Repeater
Perle Systems, a global provider of advanced Ethernet device networking hardware, today announced an uncomplicated Ethernet Repeater with advanced features to ensure reliable data transmission. Each point to point eR-S1110 Ethernet Repeater extends the network data transmission distance an additional 100m (328ft) over standard CAT5/6/7 cables. There is a growing demand to extend Ethernet services beyond the specified limit of 100 meters, comments John Feeney, COO at Perle Systems. Quite often, an
KVT-ER split cable gland with IP65 - IP68 certification
The KVT-ER is the newest addition to the existing range of split cable glands. The extremely robust KVT-ER is used for routing and sealing of cables with and without connectors, hydraulic and pneumatic hoses. The cable gland is based on cut-outs in standard metric sizes M32, M50 and M63. The KVT-ER fulfills the IP protection ratings IP65, IP66, IP67 and IP68 - certified according to EN 60529. The high protection ratings
Global Vegetable Capsules Market 2018 - Capsugel, Er-kang, Aenova, SIRIO
Apex Market Reports, recently published a detailed market research study focused on the “Vegetable Capsules Market” across the global, regional and country level. The report provides 360° analysis of “Vegetable Capsules Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Vegetable Capsules on
ER Wagner adding 600-ton Servo Punch Press
Milwaukee-based ER Wagner announced it will have a new 600-ton Servo Punch Press available for production in late 2017, greatly increasing ER Wagner’s metal stamping capabilities. The Nidec Minster Corporation machine, which will be a part of ER Wagner’s new 157,000-square-foot corporate headquarters and state of the art manufacturing facility currently under construction in the Village of Menomonee Falls, Wis., is latest technology in metal stamping, giving the company the ability
OPTCORE Release 10GBase-ER SFP+ Optical Transceiver (10G SFP+ ER Optical Transce …
Optcore Technology, a professional fiber optical transceiver and fiber media converters supplier, is pleased to announce the 10GBase-ER SFP+ Transceiver for 10G Ethernet and OC-192/STM-64 SONET/SDH Transport. OPTCORE's 10Gb/s SFP+ ER transceiver module complies with the 802.3ae 10GBASE-ER/EW electrical interface and the SFF-8431 specifications for 10 Gigabit SFP+ small form factor pluggable module. The SFP+ ER Transceiver module uses 1550nm cooled EML transmitter with TEC and PIN photo-detector for single mode
ER Doctors Urgent Care Achieves Urgent Care Center Accreditation
ER Doctors Urgent Care, an Urgent Care clinic in Wellington, Florida has achieved Urgent Care Center Accreditation from the American Academy of Urgent Care Medicine (AAUCM). ER Doctors Urgent Care has taken the best of one medical concept, trained Emergency Room physicians and staff, and combined it with another, a relaxed, professional setting for their patients. The result is a well-run Urgent Care center in a growing residential area,